DOCSLIB.ORG

Reconstructing Dynamic Microrna-Regulated Interaction Networks

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Reconstructing Dynamic Microrna-Regulated Interaction Networks Reconstructing dynamic microRNA-regulated interaction networks Marcel H. Schulza, Kusum V. Panditb, Christian L. Lino Cardenasb, Namasivayam Ambalavananc, Naftali Kaminskib, and Ziv Bar-Josepha,d,1 aRay and Stephanie Lane Center for Computational Biology, School of Computer Science, Carnegie Mellon University, Pittsburgh, PA 15213; bDorothy P. and Richard P. Simmons Center for Interstitial Lung Disease, Division of Pulmonary, Allergy, and Critical Care Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213; cDepartments of Pediatrics, Centers for Free Radical Biology and Pulmonary Injury Repair Center, University of Alabama at Birmingham, Birmingham, AL 35249; and dMachine Learning Department, School of Computer Science, Carnegie Mellon University, Pittsburgh, PA 15213 Edited by Howard Y. Chang, Stanford University, Stanford, CA, and accepted by the Editorial Board July 31, 2013 (received for review February 20, 2013) The regulation of gene expression in cells, including by microRNAs dynamics of miRNA-regulated networks. Specifically, although (miRNAs), is a dynamic process. Current methods for identifying these methods look for global relationships between the expression miRNA targets by combining sequence and miRNA and mRNA levels of an miRNA and its targets, they may miss important tem- expression data do not adequately use the temporal information poral aspects. Similar to other causal events (11), shifts in miRNA and thus miss important miRNAs and their targets. We developed and mRNA profiles in a specific developmental stage or disease the MIRna Dynamic Regulatory Events Miner (mirDREM), a proba- state can happen in a sequential manner. Static, correlation-based bilistic modeling method that uses input–output hidden Markov analysis may miss key regulatory miRNAs when these change at models to reconstruct dynamic regulatory networks that explain an earlier stage and so their global expression levels do not how temporal gene expression is jointly regulated by miRNAs and correlate with their targets. transcription factors. We measured miRNA and mRNA expression To address this problem, we developed the MIRna Dynamic Regulatory Events Miner (mirDREM), which reconstructs dy- for postnatal lung development in mice and used mirDREM to namic regulatory networks that model the effects of transcription study the regulation of this process. The reconstructed dynamic fi factors (TFs) and miRNAs on their targets over time. Such dy- network correctly identi ed known miRNAs and transcription namic network models have been used for studying TF activity factors. The method has also provided predictions about addi- fi (12, 13); however, they have only used the TF data as static in- tional miRNAs regulating this process and the speci c develop- formation (i.e., whether a TF can bind a gene or not). Although TF mental phases they regulate, several of which were experimentally activity is often posttranscriptionally regulated (12), miRNA ex- validated. Our analysis uncovered links between miRNAs involved pression levels are an excellent indicator of their activity level and in lung development and differentially expressed miRNAs in socanbeusedtodetermineifaspecific miRNA is actively regu- idiopathic pulmonary fibrosis patients, some of which we have lating genes. We have developed computational methods for using experimentally validated using proliferation assays. These dynamic activity information and for restricting the assignments results indicate that some disease progression pathways in id- of miRNAs to targets based on their expected inhibitory effects. iopathic pulmonary fibrosis may represent partial reversal of To test our method, we generated expression data for lung lung differentiation. development in mice. When applied to these data, mirDREM was able to identify several miRNAs that were controlling major systems biology | network modeling developmental stages, several of which we have experimentally validated. any experiments now routinely profile both mRNAs and Results MmicroRNAs (miRNAs) when studying various conditions, The Dynamic Regulatory Events Miner (DREM). mirDREM extends diseases, and biological processes. Most miRNAs target the the dynamic regulatory events miner (DREM) (12, 13) to model genes they regulate by either degrade them or preventing them regulation by miRNAs. DREM integrates time series gene ex- from being translated (1). It is estimated that miRNAs regulate pression data with protein–DNA interaction data (from ChIP- the expression of half of the genes in the human genome (2). CHIP, ChIP-Sequencing, or motif information). DREM uses an Although a single miRNA can target hundreds of genes, miR- input–output hidden Markov model (IOHMM) to identify bi- NAs often have overlapping targets and are acting combinato- furcation events, which are places in the time series where a set rially, thus creating a rich and complex regulatory network (3, 4). of genes that were previously coexpressed diverges. These split Several computational methods were developed to identify events are annotated with TFs that are predicted to regulate miRNA targets using sequence analysis (1). Because of the small genes in the outgoing upward and/or downward paths, allowing number of bases in the interface, such predictions often contain both false positives and false negatives (5) and, because they are context-independent, are less suitable to the analysis of specific Author contributions: M.H.S., K.V.P., C.L.L.C., N.A., N.K., and Z.B.-J. designed research; responses and conditions. Because miRNAs often inhibit their M.H.S., K.V.P., C.L.L.C., and N.A. performed research; M.H.S. contributed new reagents/ direct targets, integrating sequence, mRNA and miRNA ex- analytic tools; M.H.S. and K.V.P. analyzed data; and M.H.S., K.V.P., N.K., and Z.B.-J. wrote pression data are one way to improve such an analysis (6–8). the paper. Several methods, mostly based on (anti-) correlation or regression Conflict of interest statement: N.K. is an inventor on use of microRNAs for the diagnosis and treatment of lung fibrosis. analysis, have been developed to use expression data when pre- – This article is a PNAS Direct Submission. H.Y.C. is a guest editor invited by the Editorial dicting targets of miRNAs (8 10). A representative example is Board. GenMIR++ (5, 6), one of the first methods to integrate miRNA fi fi Data deposition: The data reported in this paper have been deposited in the Gene Ex- and mRNA expression pro les in a uni ed probabilistic model. pression Omnibus (GEO) database, www.ncbi.nlm.nih.gov/geo [accession nos. GSE41412 GenMIR++ employs a generative model in which miRNA ex- (time series expression data) and GSE41607 (gene expression data after transfection)]. pression profiles are used to explain the expression of a putative mirDREM is available from www.sb.cs.cmu.edu/drem. target inferred from sequence analysis. Other methods search for See Commentary on page 15516. anticorrelation (8, 9). 1To whom correspondence should be addressed. E-mail: [email protected]. Although the methods mentioned were successfully applied to This article contains supporting information online at www.pnas.org/lookup/suppl/doi:10. study gene regulation by miRNAs, they do not address the temporal 1073/pnas.1303236110/-/DCSupplemental. 15686–15691 | PNAS | September 24, 2013 | vol. 110 | no. 39 www.pnas.org/cgi/doi/10.1073/pnas.1303236110 Downloaded by guest on October 2, 2021 us to associate temporal information (the timing of the splits, has been performed to study various regulatory networks activated Fig. 1) with the often static protein–DNA interaction data. Unlike during lung development (19), relatively little is known about the SEE COMMENTARY standard HMMs, which rely on a transition probability matrix, temporal role miRNAs play in this process. DREM uses an L1 logistic regression classifier to determine tran- We measured lung mRNA and miRNA expression levels at sition probabilities. five developmental time points with four to five biological rep- Although DREM can be used to model regulation by miRNAs licates collected for each time point (0, 4, 7, 14, and 42 d; (using a set of predicted targets as static data), such an approach Materials and Methods). We used mirDREM to combine the does not fully use miRNA expression data. DREM does not use temporal mRNA and miRNA expression data with static TF– the expression levels of TFs because several TFs are posttran- gene interaction data (20) and miRNA–gene interaction pre- scriptionally regulated and so their expression levels do not al- dictions from the Microcosm database [which uses the miRanda ways correspond to their activity level (12). In contrast, miRNAs algorithm (21)]. The reconstructed dynamic network is shown in are transcriptionally regulated and in the majority of cases their Fig. 2. mirDREM identified a network with eight split nodes (SI expression levels directly correspond to their activity. In addition, Appendix, Dataset S1), with the biggest changes occurring in the unlike TFs that can serve as activators or repressors, miRNAs week 1 to week 2 transition. This agrees well with current knowl- directly repress their targets, leading to anticorrelated expression edge regarding lung development. Rapid alveolar septation is levels between miRNAs and their targets (1, 8, 9, 10, 14). Finally, known to occur between postnatal days 7 and 14 (P7–P14), and miRNAs often target fewer genes than TFs and their impact on the majority of alveolar septation is complete by P14 (22), al- each of their targets
Load more

Recommended publications
  • Activated Peripheral-Blood-Derived Mononuclear Cells
    Transcription factor expression in lipopolysaccharide- activated peripheral-blood-derived mononuclear cells Jared C. Roach*†, Kelly D. Smith*‡, Katie L. Strobe*, Stephanie M. Nissen*, Christian D. Haudenschild§, Daixing Zhou§, Thomas J. Vasicek¶, G. A. Heldʈ, Gustavo A. Stolovitzkyʈ, Leroy E. Hood*†, and Alan Aderem* *Institute for Systems Biology, 1441 North 34th Street, Seattle, WA 98103; ‡Department of Pathology, University of Washington, Seattle, WA 98195; §Illumina, 25861 Industrial Boulevard, Hayward, CA 94545; ¶Medtronic, 710 Medtronic Parkway, Minneapolis, MN 55432; and ʈIBM Computational Biology Center, P.O. Box 218, Yorktown Heights, NY 10598 Contributed by Leroy E. Hood, August 21, 2007 (sent for review January 7, 2007) Transcription factors play a key role in integrating and modulating system. In this model system, we activated peripheral-blood-derived biological information. In this study, we comprehensively measured mononuclear cells, which can be loosely termed ‘‘macrophages,’’ the changing abundances of mRNAs over a time course of activation with lipopolysaccharide (LPS). We focused on the precise mea- of human peripheral-blood-derived mononuclear cells (‘‘macro- surement of mRNA concentrations. There is currently no high- phages’’) with lipopolysaccharide. Global and dynamic analysis of throughput technology that can precisely and sensitively measure all transcription factors in response to a physiological stimulus has yet to mRNAs in a system, although such technologies are likely to be be achieved in a human system, and our efforts significantly available in the near future. To demonstrate the potential utility of advanced this goal. We used multiple global high-throughput tech- such technologies, and to motivate their development and encour- nologies for measuring mRNA levels, including massively parallel age their use, we produced data from a combination of two distinct signature sequencing and GeneChip microarrays.
    [Show full text]
  • Replication of FTO Gene Associated with Lean Mass in a Meta
    www.nature.com/scientificreports OPEN Replication of FTO Gene associated with lean mass in a Meta-Analysis of Genome-Wide Association Studies Shu Ran1, Zi-Xuan Jiang1, Xiao He1, Yu Liu1, Yu-Xue Zhang1, Lei Zhang2,3, Yu-Fang Pei3,4, Meng Zhang5, Rong Hai6, Gui-Shan Gu7, Bao-Lin Liu1, Qing Tian8, Yong-Hong Zhang3,4, Jing-Yu Wang7 & Hong-Wen Deng8* Sarcopenia is characterized by low skeletal muscle, a complex trait with high heritability. With the dramatically increasing prevalence of obesity, obesity and sarcopenia occur simultaneously, a condition known as sarcopenic obesity. Fat mass and obesity-associated (FTO) gene is a candidate gene of obesity. To identify associations between lean mass and FTO gene, we performed a genome-wide association study (GWAS) of lean mass index (LMI) in 2207 unrelated Caucasian subjects and replicated major fndings in two replication samples including 6,004 unrelated Caucasian and 38,292 unrelated Caucasian. We found 29 single nucleotide polymorphisms (SNPs) in FTO signifcantly associated with sarcopenia (combined p-values ranging from 5.92 × 10−12 to 1.69 × 10−9). Potential biological functions of SNPs were analyzed by HaploReg v4.1, RegulomeDB, GTEx, IMPC and STRING. Our results provide suggestive evidence that FTO gene is associated with lean mass. Sarcopenia is a complex disease described as the age-associated loss of skeletal muscle mass, strength and func- tion impairment1,2. Te low skeletal muscle mass will lead to many public health problems such as sarcopenia, osteoporosis and increased mortality3,4, especially in the elderly. Skeletal muscle is heritable with heritability esti- mates of 30–85% for muscle strength and 45–90% for muscle mass5.
    [Show full text]
  • Molecular Profile of Tumor-Specific CD8+ T Cell Hypofunction in a Transplantable Murine Cancer Model
    Downloaded from http://www.jimmunol.org/ by guest on September 25, 2021 T + is online at: average * The Journal of Immunology , 34 of which you can access for free at: 2016; 197:1477-1488; Prepublished online 1 July from submission to initial decision 4 weeks from acceptance to publication 2016; doi: 10.4049/jimmunol.1600589 http://www.jimmunol.org/content/197/4/1477 Molecular Profile of Tumor-Specific CD8 Cell Hypofunction in a Transplantable Murine Cancer Model Katherine A. Waugh, Sonia M. Leach, Brandon L. Moore, Tullia C. Bruno, Jonathan D. Buhrman and Jill E. Slansky J Immunol cites 95 articles Submit online. Every submission reviewed by practicing scientists ? is published twice each month by Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts http://jimmunol.org/subscription Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html http://www.jimmunol.org/content/suppl/2016/07/01/jimmunol.160058 9.DCSupplemental This article http://www.jimmunol.org/content/197/4/1477.full#ref-list-1 Information about subscribing to The JI No Triage! Fast Publication! Rapid Reviews! 30 days* Why • • • Material References Permissions Email Alerts Subscription Supplementary The Journal of Immunology The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2016 by The American Association of Immunologists, Inc. All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. This information is current as of September 25, 2021. The Journal of Immunology Molecular Profile of Tumor-Specific CD8+ T Cell Hypofunction in a Transplantable Murine Cancer Model Katherine A.
    [Show full text]
  • Table S1 the Four Gene Sets Derived from Gene Expression Profiles of Escs and Differentiated Cells
    Table S1 The four gene sets derived from gene expression profiles of ESCs and differentiated cells Uniform High Uniform Low ES Up ES Down EntrezID GeneSymbol EntrezID GeneSymbol EntrezID GeneSymbol EntrezID GeneSymbol 269261 Rpl12 11354 Abpa 68239 Krt42 15132 Hbb-bh1 67891 Rpl4 11537 Cfd 26380 Esrrb 15126 Hba-x 55949 Eef1b2 11698 Ambn 73703 Dppa2 15111 Hand2 18148 Npm1 11730 Ang3 67374 Jam2 65255 Asb4 67427 Rps20 11731 Ang2 22702 Zfp42 17292 Mesp1 15481 Hspa8 11807 Apoa2 58865 Tdh 19737 Rgs5 100041686 LOC100041686 11814 Apoc3 26388 Ifi202b 225518 Prdm6 11983 Atpif1 11945 Atp4b 11614 Nr0b1 20378 Frzb 19241 Tmsb4x 12007 Azgp1 76815 Calcoco2 12767 Cxcr4 20116 Rps8 12044 Bcl2a1a 219132 D14Ertd668e 103889 Hoxb2 20103 Rps5 12047 Bcl2a1d 381411 Gm1967 17701 Msx1 14694 Gnb2l1 12049 Bcl2l10 20899 Stra8 23796 Aplnr 19941 Rpl26 12096 Bglap1 78625 1700061G19Rik 12627 Cfc1 12070 Ngfrap1 12097 Bglap2 21816 Tgm1 12622 Cer1 19989 Rpl7 12267 C3ar1 67405 Nts 21385 Tbx2 19896 Rpl10a 12279 C9 435337 EG435337 56720 Tdo2 20044 Rps14 12391 Cav3 545913 Zscan4d 16869 Lhx1 19175 Psmb6 12409 Cbr2 244448 Triml1 22253 Unc5c 22627 Ywhae 12477 Ctla4 69134 2200001I15Rik 14174 Fgf3 19951 Rpl32 12523 Cd84 66065 Hsd17b14 16542 Kdr 66152 1110020P15Rik 12524 Cd86 81879 Tcfcp2l1 15122 Hba-a1 66489 Rpl35 12640 Cga 17907 Mylpf 15414 Hoxb6 15519 Hsp90aa1 12642 Ch25h 26424 Nr5a2 210530 Leprel1 66483 Rpl36al 12655 Chi3l3 83560 Tex14 12338 Capn6 27370 Rps26 12796 Camp 17450 Morc1 20671 Sox17 66576 Uqcrh 12869 Cox8b 79455 Pdcl2 20613 Snai1 22154 Tubb5 12959 Cryba4 231821 Centa1 17897
    [Show full text]
  • The Activator Protein-1 Transcription Factor in Respiratory Epithelium Carcinogenesis
    Subject Review The Activator Protein-1 Transcription Factor in Respiratory Epithelium Carcinogenesis Michalis V. Karamouzis,1 Panagiotis A. Konstantinopoulos,1,2 and Athanasios G. Papavassiliou1 1Department of Biological Chemistry, Medical School, University of Athens, Athens, Greece and 2Division of Hematology-Oncology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts Abstract Much of the current anticancer research effort is focused on Respiratory epithelium cancers are the leading cause cell-surface receptors and their cognate upstream molecules of cancer-related death worldwide. The multistep natural because they provide the easiest route for drugs to affect history of carcinogenesis can be considered as a cellular behavior, whereas agents acting at the level of gradual accumulation of genetic and epigenetic transcription need to invade the nucleus. However, the aberrations, resulting in the deregulation of cellular therapeutic effect of surface receptor manipulation might be homeostasis. Growing evidence suggests that cross- considered less than specific because their actions are talk between membrane and nuclear receptor signaling modulated by complex interacting downstream signal trans- pathways along with the activator protein-1 (AP-1) duction pathways. A pivotal transcription factor during cascade and its cofactor network represent a pivotal respiratory epithelium carcinogenesis is activator protein-1 molecular circuitry participating directly or indirectly in (AP-1). AP-1–regulated genes include important modulators of respiratory epithelium carcinogenesis. The crucial role invasion and metastasis, proliferation, differentiation, and of AP-1 transcription factor renders it an appealing survival as well as genes associated with hypoxia and target of future nuclear-directed anticancer therapeutic angiogenesis (7). Nuclear-directed therapeutic strategies might and chemoprevention approaches.
    [Show full text]
  • NFIL3 Mutations Alter Immune Homeostasis and Sensitise For
    Ann Rheum Dis: first published as 10.1136/annrheumdis-2018-213764 on 14 December 2018. Downloaded from Basic and translational research EXTENDED REPORT NFIL3 mutations alter immune homeostasis and sensitise for arthritis pathology Susan Schlenner,1,2 Emanuela Pasciuto,1,2 Vasiliki Lagou,1,2 Oliver Burton,1,2 Teresa Prezzemolo,1,2 Steffie Junius,1,2 Carlos P Roca,1,2 Cyril Seillet,3,4 Cynthia Louis,3 James Dooley,1,2 Kylie Luong,3,4 Erika Van Nieuwenhove,1,2,5 Ian P Wicks,3,4 Gabrielle Belz,3,4 Stéphanie Humblet-Baron,1,2 Carine Wouters,1,5 Adrian Liston1,2 Handling editor Josef S ABSTRact Key messages Smolen Objectives NFIL3 is a key immunological transcription factor, with knockout mice studies identifying functional ► Additional material is Homozygous NFIL3 mutations identified in roles in multiple immune cell types. Despite the importance ► published online only. To view monozygotic twins with juvenile idiopathic please visit the journal online of NFIL3, little is known about its function in humans. arthritis. (http:// dx. doi. org/ 10. 1136/ Methods Here, we characterised a kindred of two Enhanced susceptibility to arthritis induction in annrheumdis- 2018- 213764). monozygotic twin girls with juvenile idiopathic arthritis at ► Nfil3-knockout mice. 1 the genetic and immunological level, using whole exome Department of Microbiology NFIL3 loss in patients and mice is associated sequencing, single cell sequencing and flow cytometry. ► and Immunology, KUL - with elevated production of IL-1 . University of Leuven, Leuven, Parallel studies were performed in a mouse model. β Knockdown of NFIL3 in healthy macrophages Belgium Results The patients inherited a novel p.M170I in NFIL3 ► 2VIB Center for Brain and drives IL-1β production.
    [Show full text]
  • Supplemental Materials ZNF281 Enhances Cardiac Reprogramming
    Supplemental Materials ZNF281 enhances cardiac reprogramming by modulating cardiac and inflammatory gene expression Huanyu Zhou, Maria Gabriela Morales, Hisayuki Hashimoto, Matthew E. Dickson, Kunhua Song, Wenduo Ye, Min S. Kim, Hanspeter Niederstrasser, Zhaoning Wang, Beibei Chen, Bruce A. Posner, Rhonda Bassel-Duby and Eric N. Olson Supplemental Table 1; related to Figure 1. Supplemental Table 2; related to Figure 1. Supplemental Table 3; related to the “quantitative mRNA measurement” in Materials and Methods section. Supplemental Table 4; related to the “ChIP-seq, gene ontology and pathway analysis” and “RNA-seq” and gene ontology analysis” in Materials and Methods section. Supplemental Figure S1; related to Figure 1. Supplemental Figure S2; related to Figure 2. Supplemental Figure S3; related to Figure 3. Supplemental Figure S4; related to Figure 4. Supplemental Figure S5; related to Figure 6. Supplemental Table S1. Genes included in human retroviral ORF cDNA library. Gene Gene Gene Gene Gene Gene Gene Gene Symbol Symbol Symbol Symbol Symbol Symbol Symbol Symbol AATF BMP8A CEBPE CTNNB1 ESR2 GDF3 HOXA5 IL17D ADIPOQ BRPF1 CEBPG CUX1 ESRRA GDF6 HOXA6 IL17F ADNP BRPF3 CERS1 CX3CL1 ETS1 GIN1 HOXA7 IL18 AEBP1 BUD31 CERS2 CXCL10 ETS2 GLIS3 HOXB1 IL19 AFF4 C17ORF77 CERS4 CXCL11 ETV3 GMEB1 HOXB13 IL1A AHR C1QTNF4 CFL2 CXCL12 ETV7 GPBP1 HOXB5 IL1B AIMP1 C21ORF66 CHIA CXCL13 FAM3B GPER HOXB6 IL1F3 ALS2CR8 CBFA2T2 CIR1 CXCL14 FAM3D GPI HOXB7 IL1F5 ALX1 CBFA2T3 CITED1 CXCL16 FASLG GREM1 HOXB9 IL1F6 ARGFX CBFB CITED2 CXCL3 FBLN1 GREM2 HOXC4 IL1F7
    [Show full text]
  • Transcriptional Control of Tissue-Resident Memory T Cell Generation
    Transcriptional control of tissue-resident memory T cell generation Filip Cvetkovski Submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy in the Graduate School of Arts and Sciences COLUMBIA UNIVERSITY 2019 © 2019 Filip Cvetkovski All rights reserved ABSTRACT Transcriptional control of tissue-resident memory T cell generation Filip Cvetkovski Tissue-resident memory T cells (TRM) are a non-circulating subset of memory that are maintained at sites of pathogen entry and mediate optimal protection against reinfection. Lung TRM can be generated in response to respiratory infection or vaccination, however, the molecular pathways involved in CD4+TRM establishment have not been defined. Here, we performed transcriptional profiling of influenza-specific lung CD4+TRM following influenza infection to identify pathways implicated in CD4+TRM generation and homeostasis. Lung CD4+TRM displayed a unique transcriptional profile distinct from spleen memory, including up-regulation of a gene network induced by the transcription factor IRF4, a known regulator of effector T cell differentiation. In addition, the gene expression profile of lung CD4+TRM was enriched in gene sets previously described in tissue-resident regulatory T cells. Up-regulation of immunomodulatory molecules such as CTLA-4, PD-1, and ICOS, suggested a potential regulatory role for CD4+TRM in tissues. Using loss-of-function genetic experiments in mice, we demonstrate that IRF4 is required for the generation of lung-localized pathogen-specific effector CD4+T cells during acute influenza infection. Influenza-specific IRF4−/− T cells failed to fully express CD44, and maintained high levels of CD62L compared to wild type, suggesting a defect in complete differentiation into lung-tropic effector T cells.
    [Show full text]
  • An Enhancer Directs Differential Expression of the Linked Mrf4 and Myf5 Myogenic Regulatory Genes in the Mouse
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Elsevier - Publisher Connector Developmental Biology 269 (2004) 595–608 www.elsevier.com/locate/ydbio An enhancer directs differential expression of the linked Mrf4 and Myf5 myogenic regulatory genes in the mouse Ted Hung-Tse Chang, Michael Primig,1 Juliette Hadchouel,2 Shahragim Tajbakhsh,3 Didier Rocancourt, Anne Fernandez,4 Roland Kappler,5 Harry Scherthan,6 and Margaret Buckingham* De´partement de Biologie du De´veloppement, CNRS URA 2578, Institut Pasteur, 75724 Paris Cedex 15, France Received for publication 25 September 2003, revised 3 February 2004, accepted 6 February 2004 Abstract The myogenic regulatory factors, Mrf4 and Myf5, play a key role in skeletal muscle formation. An enhancer trap approach, devised to isolate positive-acting elements from a 200-kb YAC covering the mouse Mrf4–Myf5 locus in a C2 myoblast assay, yielded an enhancer, A17, which mapped at À8kb5V of Mrf4 and À17 kb 5V of Myf5. An E-box bound by complexes containing the USF transcription factor is critical for enhancer activity. In transgenic mice, A17 gave two distinct and mutually exclusive expression profiles before birth, which correspond to two phases of Mrf4 transcription. Linked to the Tk or Mrf4 minimal promoters, the nlacZ reporter was expressed either in embryonic myotomes, or later in fetal muscle, with the majority of Mrf4 lines showing embryonic expression. When linked to the Myf5 minimal promoter, only fetal muscle expression was detected. These observations identify A17 as a sequence that targets sites of myogenesis in vivo and raise questions about the mutually exclusive modes of expression and possible promoter/enhancer interactions at the Mrf4–Myf5 locus.
    [Show full text]
  • A Flexible Microfluidic System for Single-Cell Transcriptome Profiling
    www.nature.com/scientificreports OPEN A fexible microfuidic system for single‑cell transcriptome profling elucidates phased transcriptional regulators of cell cycle Karen Davey1,7, Daniel Wong2,7, Filip Konopacki2, Eugene Kwa1, Tony Ly3, Heike Fiegler2 & Christopher R. Sibley 1,4,5,6* Single cell transcriptome profling has emerged as a breakthrough technology for the high‑resolution understanding of complex cellular systems. Here we report a fexible, cost‑efective and user‑ friendly droplet‑based microfuidics system, called the Nadia Instrument, that can allow 3′ mRNA capture of ~ 50,000 single cells or individual nuclei in a single run. The precise pressure‑based system demonstrates highly reproducible droplet size, low doublet rates and high mRNA capture efciencies that compare favorably in the feld. Moreover, when combined with the Nadia Innovate, the system can be transformed into an adaptable setup that enables use of diferent bufers and barcoded bead confgurations to facilitate diverse applications. Finally, by 3′ mRNA profling asynchronous human and mouse cells at diferent phases of the cell cycle, we demonstrate the system’s ability to readily distinguish distinct cell populations and infer underlying transcriptional regulatory networks. Notably this provided supportive evidence for multiple transcription factors that had little or no known link to the cell cycle (e.g. DRAP1, ZKSCAN1 and CEBPZ). In summary, the Nadia platform represents a promising and fexible technology for future transcriptomic studies, and other related applications, at cell resolution. Single cell transcriptome profling has recently emerged as a breakthrough technology for understanding how cellular heterogeneity contributes to complex biological systems. Indeed, cultured cells, microorganisms, biopsies, blood and other tissues can be rapidly profled for quantifcation of gene expression at cell resolution.
    [Show full text]
  • ELF2 Antibody - N-Terminal Region Rabbit Polyclonal Antibody Catalog # AI10026
    10320 Camino Santa Fe, Suite G San Diego, CA 92121 Tel: 858.875.1900 Fax: 858.622.0609 ELF2 antibody - N-terminal region Rabbit Polyclonal Antibody Catalog # AI10026 Specification ELF2 antibody - N-terminal region - Product Information Application WB Primary Accession Q15723 Other Accession Q15723-3, NP_006865, NM_006874 Reactivity Human, Mouse, Rat, Rabbit, Dog, Guinea Pig, Horse, Bovine Predicted Human, Mouse, ELF2 antibody - N-terminal region (AI10026) Rat, Rabbit, in Hum. Fetal Heart cells using Western Blot Chicken, Dog, Host: Rabbit Guinea Pig, Horse, Bovine Target Name: ELF2 Host Rabbit Sample Tissue: Human Fetal Heart Clonality Polyclonal Antibody Dilution: 1.0μg/ml Calculated MW 57 kDa KDa ELF2 antibody - N-terminal region - Additional Information Gene ID 1998 Alias Symbol EU32, NERF, NERF-2, NERF-1A, NERF-1B, NERF-1a,b Other Names ETS-related transcription factor Elf-2, ELF2 antibody - N-terminal region (AI10026) E74-like factor 2, New ETS-related factor, in Hum. Fetal Lung cells using Western Blot ELF2 {ECO:0000312|EMBL:AAF671951} Host: Rabbit Target Name: ELF2 Target/Specificity Sample Tissue: Human Fetal Lung The ELF2 gene encodes a protein that Antibody Dilution: 1.0μg/ml physically interacts with AML1 and mediates opposing effects on AML1-mediated transcription of the B cell-specific blk gene. Format Liquid. Purified antibody supplied in 1x PBS buffer with 0.09% (w/v) sodium azide and 2% sucrose. Page 1/2 10320 Camino Santa Fe, Suite G San Diego, CA 92121 Tel: 858.875.1900 Fax: 858.622.0609 Reconstitution & Storage Add 50 ul of distilled water. Final anti-ELF2 antibody concentration is 1 mg/ml in PBS buffer with 2% sucrose.
    [Show full text]
  • Junb and GATA3 Transcription Factors Cytokine Expression Through Regulating CARMA1 Controls Th2 Cell-Specific
    CARMA1 Controls Th2 Cell-Specific Cytokine Expression through Regulating JunB and GATA3 Transcription Factors This information is current as Marzenna Blonska, Donghyun Joo, Patrick A. of September 27, 2021. Zweidler-McKay, Qingyu Zhao and Xin Lin J Immunol published online 27 February 2012 http://www.jimmunol.org/content/early/2012/02/26/jimmun ol.1102943 Downloaded from Supplementary http://www.jimmunol.org/content/suppl/2012/02/27/jimmunol.110294 Material 3.DC1 http://www.jimmunol.org/ Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication by guest on September 27, 2021 *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2012 by The American Association of Immunologists, Inc. All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. Published February 27, 2012, doi:10.4049/jimmunol.1102943 The Journal of Immunology CARMA1 Controls Th2 Cell-Specific Cytokine Expression through Regulating JunB and GATA3 Transcription Factors Marzenna Blonska,* Donghyun Joo,*,† Patrick A. Zweidler-McKay,‡ Qingyu Zhao,*,1 and Xin Lin*,† The scaffold protein CARMA1 is required for the TCR-induced lymphocyte activation.
    [Show full text]